Cortigent Showcases Orion Brain Implant Clinical Progress
EMERYVILLE, Calif., January 22, 2026 — Vivani Medical announced that its wholly owned subsidiary Cortigent will present advanced clinical...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
EMERYVILLE, Calif., January 22, 2026 — Vivani Medical announced that its wholly owned subsidiary Cortigent will present advanced clinical...
SAN JOSÉ, Costa Rica, Dec. 29, 2025 — Establishment Labs has submitted a regulatory application to the U.S. Food...
